![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, February 10, 2005 2:26:06 PM
$40,000 to carry out a validation of Retinome. Think of the questions that raises.
Isn't Retinome already validated?
Has it been released without sufficient validation?
If it has already been validated, why does the Australian Government not accept the data, why does it need to be redone?
$40,000 dollars, gimme a break, can't DNAP perform it's own validation and present the results in such a way as to satisfy those involved without approaching them with hat in hand for such a paltry handout?
Doesn't appear to be the behavior of a major player, does it?
Let's hope it was just fluff...what do you think?
regards,
frog
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM